查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386387

家禽疫苗市場報告：2030 年趨勢、預測與競爭分析

Poultry Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

家禽疫苗趨勢和預測

預計到 2030 年，全球家禽疫苗市場將達到 24 億美元，2024 年至 2030 年年複合成長率為 5.1%。該市場的主要驅動力配合措施與家禽健康相關的需求不斷成長、家禽中通用感染疾病的患病率增加以及遏制抗菌素抗藥性的意識和努力的提高。全球家禽疫苗市場前景廣闊，支氣管炎、禽流感、新城疫、馬立克氏症市場蘊藏商機。

家禽疫苗市場洞察

Lucintel 預測，減毒活病毒疫苗將繼續成為最大的市場，因為它們具有較長的免疫力和對傳染性支氣管炎、傳染性黏液囊炎和新城疫等禽類疾病的保護作用。

由於世界各地禽病流行率不斷上升，禽流感將繼續成為該市場的最大部分。

由於該地區家禽產品消費量的增加以及消費者食品安全意識的提高，北美將繼續成為最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球家禽疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球家禽疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 全球家禽疫苗市場（按產品）
    • 減毒活病毒疫苗
    • 去活化疫苗
    • 重組疫苗
  • 按疾病類型分類的全球家禽疫苗市場
    • 支氣管炎
    • 禽流感
    • 新城疫
    • 馬立克氏症
    • 其他
  • 全球家禽疫苗市場按應用
    • 肉雞
    • 蛋雞
    • 種雞

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球家禽疫苗市場區域分佈
  • 北美洲家禽疫苗市場
  • 歐洲家禽疫苗市場
  • 亞太地區家禽疫苗市場
  • 其他區域家禽疫苗市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球家禽疫苗市場成長機會（按產品）
    • 按疾病類型分類的全球家禽疫苗市場成長機會
    • 全球家禽疫苗市場成長機會（按應用）
    • 全球家禽疫苗市場成長機會（按地區）
  • 全球家禽疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球家禽疫苗市場產能擴張
    • 全球家禽疫苗市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Bio-Vet
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Elanco
  • Merck
  • Phibro Animal Health
  • Venkys
  • Zoetis
  • Vaxxinova International
  • Venkys India
簡介目錄

Poultry Vaccine Trends and Forecast

The future of the global poultry vaccine market looks promising with opportunities in the bronchitis, avian influenza, newcastle disease, and Marek's disease markets. The global poultry vaccine market is expected to reach an estimated $2.4 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are escalating demand for the poultry health coupled, rising prevalence of zoonotic diseases in poultry, and augmenting awareness and initiatives to curb antimicrobial resistance.

A more than 150-page report is developed to help in your business decisions.

Poultry Vaccine by Segment

The study includes a forecast for the global poultry vaccine by product, disease type, application, and region.

Poultry Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines

Poultry Vaccine Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

  • Bronchitis
  • Avian Influenza
  • Newcastle Disease
  • Marek's Disease
  • Others

Poultry Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Broiler
  • Layer
  • Breeder

Poultry Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Poultry Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies poultry vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the poultry vaccine companies profiled in this report include-

  • Bio-Vet
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Elanco
  • Merck
  • Phibro Animal Health
  • Venkys
  • Zoetis
  • Vaxxinova International
  • Venkys India

Poultry Vaccine Market Insights

Lucintel forecasts that attenuated live will remain the largest segment due to its longer immunity and protection against avian diseases such as infectious bronchitis, infectious bursal disease, and newcastle disease.

Within this market, avian influenza will remain the largest segment due to the rising prevalence of avian diseases among birds across all the countries in the world.

North America will remain the largest region due to growing consumption of poultry-derived products and escalating consumer awareness towards food safety in the region.

Features of the Global Poultry Vaccine Market

Market Size Estimates: Poultry vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Poultry vaccine market size by product, disease type, application, and region in terms of value ($B).

Regional Analysis: Poultry vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, disease types, applications, and regions for the poultry vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the poultry vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the poultry vaccine market size?

Answer: The global poultry vaccine market is expected to reach an estimated $2.4 billion by 2030.

Q.2 What is the growth forecast for poultry vaccine market?

Answer: The global poultry vaccine market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the poultry vaccine market?

Answer: The major drivers for this market are escalating demand for the poultry health coupled, rising prevalence of zoonotic diseases in poultry, and augmenting awareness and initiatives to curb antimicrobial resistance.

Q4. What are the major segments for poultry vaccine market?

Answer: The future of the poultry vaccine market looks promising with opportunities in the bronchitis, avian influenza, newcastle disease, and Marek's disease markets.

Q5. Who are the key poultry vaccine market companies?

Answer: Some of the key poultry vaccine companies are as follows:

  • Bio-Vet
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Elanco
  • Merck
  • Phibro Animal Health
  • Venkys
  • Zoetis
  • Vaxxinova International
  • Venkys India

Q6. Which poultry vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that attenuated live will remain the largest segment due to its longer immunity and protection against avian diseases such as infectious bronchitis, infectious bursal disease, and newcastle disease.

Q7. In poultry vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing consumption of poultry-derived products and escalating consumer awareness towards food safety in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the poultry vaccine market by product (attenuated live vaccines, inactivated vaccines, and recombinant vaccines), disease type (bronchitis, avian influenza, newcastle disease, Marek's disease, and others), application (broiler, layer, and breeder), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Poultry Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Poultry Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Poultry Vaccine Market by Product
    • 3.3.1: Attenuated Live Vaccines
    • 3.3.2: Inactivated Vaccines
    • 3.3.3: Recombinant Vaccines
  • 3.4: Global Poultry Vaccine Market by Disease Type
    • 3.4.1: Bronchitis
    • 3.4.2: Avian Influenza
    • 3.4.3: Newcastle disease
    • 3.4.4: Marek's Disease
    • 3.4.5: Others
  • 3.5: Global Poultry Vaccine Market by Application
    • 3.5.1: Broiler
    • 3.5.2: Layer
    • 3.5.3: Breeder

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Poultry Vaccine Market by Region
  • 4.2: North American Poultry Vaccine Market
    • 4.2.2: North American Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others
  • 4.3: European Poultry Vaccine Market
    • 4.3.1: European Poultry Vaccine Market by Product: Attenuated Live Vaccines, Inactivated Vaccines, and Recombinant Vaccines
    • 4.3.2: European Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others
  • 4.4: APAC Poultry Vaccine Market
    • 4.4.1: APAC Poultry Vaccine Market by Product: Attenuated Live Vaccines, Inactivated Vaccines, and Recombinant Vaccines
    • 4.4.2: APAC Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others
  • 4.5: ROW Poultry Vaccine Market
    • 4.5.1: ROW Poultry Vaccine Market by Product: Attenuated Live Vaccines, Inactivated Vaccines, and Recombinant Vaccines
    • 4.5.2: ROW Poultry Vaccine Market by Disease Type: Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Poultry Vaccine Market by Product
    • 6.1.2: Growth Opportunities for the Global Poultry Vaccine Market by Disease Type
    • 6.1.3: Growth Opportunities for the Global Poultry Vaccine Market by Application
    • 6.1.4: Growth Opportunities for the Global Poultry Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Poultry Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Poultry Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Poultry Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bio-Vet
  • 7.2: Boehringer Ingelheim
  • 7.3: Ceva Animal Health
  • 7.4: Elanco
  • 7.5: Merck
  • 7.6: Phibro Animal Health
  • 7.7: Venkys
  • 7.8: Zoetis
  • 7.9: Vaxxinova International
  • 7.10: Venkys India